CAS: 61925-77-7; Boc-Cys(Pmebzl)-Oh

该化合物是氨基酸囊性碳酸基(Boc)保护组的衍生物,其特点是氨基氨基基酸基基乙基碳酸酯(Boc)的保护组和与硫磺原子附属的4-甲基苯基苯基组,该化合物一般用于浸泡合成和药用化学,因为它有能力在反应中保护功能组.Boc组通常用于暂时遮盖氨基组的表面,便于不受干扰的选择性反应.4甲基苯乙烯基替代组增强了分子的亲性性和消毒特性,这可以影响分子的再活性和生物活动.它作为细胞衍生物保留了硫醇(-SH)的功能,这对形成硫化物结合并参与红毒反应至关重要.该化合物在标准实验室条件下一般保持稳定,但应对它应谨慎,因为硫基物质组具有潜在的再活动性.其应用可能扩大到药物开发,特别是在设计基于硫化的治疗中.

结构式图片

相似化合物

136050-67-4 5068-28-0 102830-49-9

上下游产品

CAS号41840-28-2 S-B°C-2-巯基-4,6-二甲基嘧啶 | CAS号42294-52-0 L-半胱氨酸 | CAS号198991-77-4 (4R)-2-(4-methy... | CAS号24424-99-5 二碳酸二叔丁酯 | CAS号52-90-4 L-半胱氨酸 | CAS号20887-95-0 B°C-L-半胱氨酸

合成工艺路线路线简述

  • 合成目标产物 Boc-S-(4-Methylbenzyl)-L-Cysteine 主要起始原料 Di-Tert-Butyl Dicarbonate
  • (文献来源)合成步骤主要原料 Di-Tert-Butyl Dicarbonate

海关参考信息

专利信息


专利号:US-4515920-A
优先权日:1984-04-30
标题 :Synthesis of peptides and proteins
发明人:ERICKSON BRUCE W
权利人:UNIV ROCKEFELLER
摘要:Solid phase synthesis of peptides and proteins have been improved by the use of a trifunctional segment, one functional group of which is bound to a solid support, the other two functional groups being available as substrates upon which identical proteins are synthesized.

专利号:US-2004110228-A1
优先权日:2002-04-01
标 题:Combinatorial organic synthesis of unique biologically active compounds
发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

专利号:WO-0050448-A1
优先权日:1999-02-26
标 题 :A method for controlling an enzymatic reaction by the alpha and beta domains of metallothionein
发明人:VALLEE BERT L; MARET WOLFGANG; FISCHER EDMOND H
权利人:VALLEE BERT L; MARET WOLFGANG; FISCHER EDMOND H
摘要:The present invention relates to the alpha and beta domains of metallothionein and analogs thereof, their synthesis, and methods for controlling in vitro and industrial enzymatic reactions using them. Purified metal-free and metal-containing alpha and beta domains of metallothionein and analogs thereof are provided as described below. A high yield method of synthesis and purification is also provided for the metal-free and metal containing alpha and beta domains of metallothionein and analogs thereof. Finally, methods for controlling in vitro and industrial enzymatic reactions are provided wherein the enzymatic processes are controlled by transfer or removal of a metal cation, to or from an enzyme metal-inhibitory site using the alpha and beta domains of metallothionein and analogs thereof.

专利号:US-4202802-A
优先权日:1978-10-02
标 题 :Peptides related to somatostatin
发明人:SHIELDS JAMES E
权利人:LILLY CO ELI
摘要:The tetradecapeptides of the formula wherein X is H-Ala-D-Ala, H-D-Ala-Gly, or H-D-Val-Gly; and X is Ala-Leu, Ala-Phe, Ala-D-Phe, D-Ala-Phe, or D-Ala-Cha; or the non-toxic, pharmaceutically acceptable acid addition salts thereof; inhibit secretion of growth hormone, while not materially inhibiting the secretion of insulin or glucagon. Intermediates used in the synthesis of the tetradecapeptides are also described.
上海吉尔多肽有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.glbiochem.com
电话: 86-21-61263309👤
📞上海吉尔多肽有限公司 ⚠️参考联系方式

销售电话:86-21-61263309
邮箱:ymbetter@glbiochem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海正极生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.bioplus.com.cn
电话: 021-64847500👤
📞上海正极生物科技有限公司 ⚠️参考联系方式

销售电话:021-64847500
邮箱:sales@bioplus.com.cn
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/978-1-0716-0227-0_3
摘要:Adhikary R, Dawson PE. In Situ Neutralization Protocols for Boc-SPPS. Methods Mol Biol. 2020;2103():29–40. doi: 10.1007/978-1-0716-0227-0_3.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知